Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Establishing method of CD36 mutant gene stable eukaryotic expression cell line causing CD36 deletion

一种突变基因、稳定表达的技术,应用在生物医学领域,能够解决CD36基因突变停留等问题

Inactive Publication Date: 2017-02-22
NAN NING INST OF TRANSFUSION MEDICINE +1
View PDF0 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] The currently reported researches on CD36 gene mutations that lead to CD36 deletion mostly focus on CD36 cDNA sequencing and prokaryotic cloning. There are no reports on the method of establishing eukaryotic stable expression cell lines of CD36 mutant genes that cause CD36 deletion in humans and related patents

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Establishing method of CD36 mutant gene stable eukaryotic expression cell line causing CD36 deletion
  • Establishing method of CD36 mutant gene stable eukaryotic expression cell line causing CD36 deletion
  • Establishing method of CD36 mutant gene stable eukaryotic expression cell line causing CD36 deletion

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0173] This example specifically introduces the eukaryotic stable expression cell of 220C>T (Gln74stop) (GenBank number: KF539919.1) CD36 mutant gene established by the establishment method of the CD36 mutant gene eukaryotic stable expression cell line of the present invention. strain, an embodiment of "220T-CD36-CHO-K1 strain".

[0174] First select a CD36-deficient individual who has been confirmed to have a C220T gene mutation by CD36 exon sequencing (this individual is marked as ZYT, see the exon sequencing results in Figure 4 ), draw 5ml of venous blood under its informed consent, EDTA anticoagulation, extract the total RNA of the blood sample, take the upstream primer YC-36F and downstream primer YC-36R of the first pair of PCR primers of the present invention, use TaKaRa One Step RNA The PCR Kit (AMV) kit reverse transcription PCR amplifies the CD36 cDNA target fragment (ZYT-CD36 cDNA), and the amplification is carried out in ABI 9700 PCR instrument. The amplification ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides an establishing method of a CD36 mutant gene stable eukaryotic expression cell line causing CD36 deletion. The method comprises a while process of extracting total RNA from a CD36 deletion individual and conducting reverse transcription so as to obtain CD36 cDNA of whole segment of a CD36 mutant gene open reading frame; establishing a recombinant cloning vector containing the CD36 mutant gene cDNA and an EGFP fluorescent reporter gene, transforming the recombinant cloning vector into escherichia coli, and conducting plasmid amplification and identification; and transfecting the recombinant cloning vector into CHO-K1 cells, and conducting screening and identification so as to obtain the CD36 mutant gene stable eukaryotic expression cell line. The CD36 is distributed in a plurality of cells and tissues, and CD36 encoding gene mutation can cause the CD36 deletion in the individual. The CD36 takes an important effect in various physiological and pathological processes, involving such diseases as platelet homologous immunization, hypercholesteremia, diabetes, malaria and the like. With the application, the CD36 mutant gene stable eukaryotic expression cell line, which is established by virtue of the technology, can provide a resource and a working platform for researching the structure and the functions of the CD36, explaining physiological and pathological mechanisms which the CD36 participate in and discussing a role in clinical treatment and drug research and development.

Description

technical field [0001] The invention relates to biomedicine, in particular to a method for establishing a eukaryotic stable expression cell line of a CD36 mutant gene that causes human CD36 loss. Background technique [0002] CD36 (leukocyte differentiation antigen 36), also known as platelet glycoprotein IV (GPIV), GP88, GPIIIb, FAT or SCARB3, belongs to the class B scavenger receptor transmembrane glycoprotein family. The protein molecule can be extensively glycosylated with a molecular mass of about 88,000. The human CD36 protein consists of 472 amino acids. CD36 protein is widely distributed in a variety of cells and tissues in the human body, including platelets, monocytes / macrophages, microvascular endothelial cells, brain microglia, astrocytes, cardiac and skeletal muscles, adipocytes, tree dendritic cells, retinal epithelial cells, and breast and kidney tissues. Its main functions include acting as receptors for thrombin receptors, collagen receptors, long-chain f...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/10C12N15/867C12N15/65C12N15/66
CPCC07K14/70503C12N15/65C12N15/66C12N15/86C12N2740/15043C12N2800/107C07K14/70596C12N9/93C12N2740/16043C12Y605/01001Y02A50/30C07K14/473C12N5/0602C12N15/85C12Q1/6806C12Q1/686C12Q1/6876
Inventor 吴国光李丽兰蒋丽红黎海燕陈洁润
Owner NAN NING INST OF TRANSFUSION MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products